As of 2025-03-27, the EV/EBITDA ratio of Sutro Biopharma Inc (STRO) is -0.41. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. STRO's latest enterprise value is 62.84 mil USD. STRO's TTM EBITDA according to its financial statements is -151.54 mil USD. Dividing these 2 quantities gives us the above STRO EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 11.0x - 12.4x | 12.1x |
| Forward P/E multiples | 16.3x - 19.0x | 16.5x |
| Fair Price | (29.56) - (22.46) | (25.87) |
| Upside | -4040.7% - -3095.3% | -3548.7% |
| Date | EV/EBITDA |